TET2 and acute myeloid leukemia: TET1 was the first representative of the TET family to be identified and was discovered as a fusion partner of MLL in people with acute myeloid leukemia carrying translocation t(10;11) (q22; q23), whereas TET2 and TET3 have been subsequently identified based on their considerable homology with the TET1 sequence [131,132].